European Commission Questions and answers Brussels, 11 Jan 2021 For months, the European Commission has been building a portfolio of several vaccines, based on different technologies, at a fair price. A common, diversified portfolio of vaccines maximises our chances of securing them at the scale needed and as quickly as possible.

Other news